DK1173418T3 - Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid - Google Patents
Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamidInfo
- Publication number
- DK1173418T3 DK1173418T3 DK00926805T DK00926805T DK1173418T3 DK 1173418 T3 DK1173418 T3 DK 1173418T3 DK 00926805 T DK00926805 T DK 00926805T DK 00926805 T DK00926805 T DK 00926805T DK 1173418 T3 DK1173418 T3 DK 1173418T3
- Authority
- DK
- Denmark
- Prior art keywords
- methoxy
- methylaminothiocarbonyl
- aminosulfonylphenyl
- benzamide
- chloro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
- C07C335/42—Sulfonylthioureas; Sulfonylisothioureas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19917233A DE19917233A1 (de) | 1999-04-16 | 1999-04-16 | Kristalline Formen des Natriumsalzes des 5-Chlor-2-methoxy-N-(2-(4-methoxy-3-methylaminothiocarbonylaminosulfonyl-phenyl)-ethyl)- benzamids |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1173418T3 true DK1173418T3 (da) | 2006-04-10 |
Family
ID=7904803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00926805T DK1173418T3 (da) | 1999-04-16 | 2000-04-04 | Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid |
Country Status (33)
Country | Link |
---|---|
US (1) | US6723751B1 (ru) |
EP (2) | EP1173418B1 (ru) |
JP (1) | JP4662640B2 (ru) |
KR (1) | KR100700302B1 (ru) |
CN (1) | CN1168712C (ru) |
AR (1) | AR023479A1 (ru) |
AT (2) | ATE311364T1 (ru) |
AU (1) | AU773246B2 (ru) |
BR (1) | BR0010658A (ru) |
CA (1) | CA2370388C (ru) |
CZ (1) | CZ302459B6 (ru) |
DE (3) | DE19917233A1 (ru) |
DK (1) | DK1173418T3 (ru) |
EE (1) | EE04612B1 (ru) |
ES (1) | ES2251996T3 (ru) |
HK (1) | HK1046270B (ru) |
HR (1) | HRP20010744B1 (ru) |
HU (1) | HU229082B1 (ru) |
IL (2) | IL145921A0 (ru) |
ME (1) | MEP55708A (ru) |
MX (1) | MXPA01010275A (ru) |
MY (1) | MY122588A (ru) |
NO (1) | NO327798B1 (ru) |
NZ (1) | NZ514788A (ru) |
PL (1) | PL203809B1 (ru) |
RS (1) | RS50916B (ru) |
RU (1) | RU2235089C2 (ru) |
SI (1) | SI1173418T1 (ru) |
SK (1) | SK287175B6 (ru) |
TR (2) | TR200501142T2 (ru) |
TW (1) | TWI276622B (ru) |
WO (1) | WO2000063167A1 (ru) |
ZA (1) | ZA200108400B (ru) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1603553E (pt) * | 2003-03-17 | 2012-02-03 | Japan Tobacco Inc | Composições farmacêuticas de inibidores de cetp |
TWI393560B (zh) * | 2003-05-02 | 2013-04-21 | Japan Tobacco Inc | 包含s-〔2(〔〔1-(2-乙基丁基)環己基〕羰基〕胺基)苯基〕2-甲基丙烷硫酯及hmg輔酶a還原酶抑制劑之組合 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2098069T3 (es) | 1993-02-23 | 1997-04-16 | Hoechst Ag | Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y su utilizacion como agentes farmaceuticos. |
DE19505397A1 (de) * | 1995-02-17 | 1996-08-22 | Hoechst Ag | Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
CA2343009C (en) * | 1998-09-10 | 2011-03-15 | Aventis Pharma Deutschland Gmbh | Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers |
-
1999
- 1999-04-16 DE DE19917233A patent/DE19917233A1/de not_active Withdrawn
-
2000
- 2000-04-04 TR TR2005/01142T patent/TR200501142T2/xx unknown
- 2000-04-04 DE DE60024431T patent/DE60024431T2/de not_active Expired - Lifetime
- 2000-04-04 RS YUP-720/01A patent/RS50916B/sr unknown
- 2000-04-04 DE DE60040811T patent/DE60040811D1/de not_active Expired - Lifetime
- 2000-04-04 AT AT00926805T patent/ATE311364T1/de active
- 2000-04-04 CA CA002370388A patent/CA2370388C/en not_active Expired - Fee Related
- 2000-04-04 DK DK00926805T patent/DK1173418T3/da active
- 2000-04-04 EP EP00926805A patent/EP1173418B1/en not_active Expired - Lifetime
- 2000-04-04 PL PL351245A patent/PL203809B1/pl unknown
- 2000-04-04 AU AU45428/00A patent/AU773246B2/en not_active Ceased
- 2000-04-04 BR BR0010658-5A patent/BR0010658A/pt not_active IP Right Cessation
- 2000-04-04 RU RU2001130886/04A patent/RU2235089C2/ru not_active IP Right Cessation
- 2000-04-04 SI SI200030775T patent/SI1173418T1/sl unknown
- 2000-04-04 JP JP2000612263A patent/JP4662640B2/ja not_active Expired - Fee Related
- 2000-04-04 KR KR1020017013220A patent/KR100700302B1/ko not_active IP Right Cessation
- 2000-04-04 NZ NZ514788A patent/NZ514788A/xx not_active IP Right Cessation
- 2000-04-04 ES ES00926805T patent/ES2251996T3/es not_active Expired - Lifetime
- 2000-04-04 CZ CZ20013672A patent/CZ302459B6/cs not_active IP Right Cessation
- 2000-04-04 CN CNB008063184A patent/CN1168712C/zh not_active Expired - Fee Related
- 2000-04-04 AT AT05024254T patent/ATE414059T1/de not_active IP Right Cessation
- 2000-04-04 MX MXPA01010275A patent/MXPA01010275A/es active IP Right Grant
- 2000-04-04 HU HU0200791A patent/HU229082B1/hu not_active IP Right Cessation
- 2000-04-04 WO PCT/EP2000/002984 patent/WO2000063167A1/en active IP Right Grant
- 2000-04-04 TR TR2001/02993T patent/TR200102993T2/xx unknown
- 2000-04-04 SK SK1458-2001A patent/SK287175B6/sk not_active IP Right Cessation
- 2000-04-04 EE EEP200100532A patent/EE04612B1/xx not_active IP Right Cessation
- 2000-04-04 IL IL14592100A patent/IL145921A0/xx active IP Right Grant
- 2000-04-04 ME MEP-557/08A patent/MEP55708A/xx unknown
- 2000-04-04 EP EP05024254A patent/EP1637519B1/en not_active Expired - Lifetime
- 2000-04-13 AR ARP000101712A patent/AR023479A1/es not_active Application Discontinuation
- 2000-04-14 US US09/549,538 patent/US6723751B1/en not_active Expired - Lifetime
- 2000-04-14 MY MYPI20001609A patent/MY122588A/en unknown
- 2000-05-10 TW TW089106840A patent/TWI276622B/zh not_active IP Right Cessation
-
2001
- 2001-10-12 ZA ZA200108400A patent/ZA200108400B/xx unknown
- 2001-10-14 IL IL145921A patent/IL145921A/en not_active IP Right Cessation
- 2001-10-15 NO NO20015014A patent/NO327798B1/no not_active IP Right Cessation
- 2001-10-15 HR HR20010744A patent/HRP20010744B1/xx not_active IP Right Cessation
-
2002
- 2002-10-30 HK HK02107874.4A patent/HK1046270B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60004317D1 (de) | Salze von Sulfonium-Verbindungen | |
IS2019B (is) | Nýtt kristallað form kalíumsalts (S)-ómeprasóls | |
EE200300001A (et) | Perindopriili tert-butüülamiinsoola kristallilinealfa-vorm | |
NO20030550D0 (no) | 17<beta>-karbotioat 17<alfa>-arylkarbonyloksyandrostanderivat som anti-inflammatoriske midler | |
NL350038I1 (nl) | Herbicidaal actieve 3-hydroxy-4-aryl-5-oxopyrazoline derivaten | |
DK1140034T3 (da) | Formulering af divalproex-natrium med kontrolleret frigivelse | |
EE200000584A (et) | Viirusevastase bensimidasoolühendi kristallilisedvormid | |
NO20016319L (no) | VLA-4 inhibitor-forbindelser | |
EE200100135A (et) | EtO2C-CH2-(R)Cgl-Aze-Pab-OH kristalsed vormid | |
HUP0202536A3 (en) | Crystals of the sodium salt of pravastatin | |
NO20013684D0 (no) | Substituerte fenetylaminderivater | |
DK1233960T3 (da) | Polymorft salt af anti-migræne lægemiddel | |
IS5821A (is) | Kristalluð form af ósanetant | |
DK1173418T3 (da) | Krystallinsk form 3 af natriumsaltet af 5-chlor-2-methoxy-N (2- (4-methoxy-3-methylaminothiocarbonyl-aminosulfonylphenyl) ethyl) benzamid | |
IS6007A (is) | Ný morfólínóbensamíðsölt | |
PT1212095E (pt) | Processo para a preparacao de uma formulacao de libertacao retardada | |
MA26840A1 (fr) | Cristaux d'inhibiteur d'echangeur sodium-hydrogene de type 1 | |
HU9904011D0 (en) | Novel salts of dipeptid derivatives | |
DK0980383T3 (da) | Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener | |
IS5544A (is) | Nýtt fosfatsalt af ísóprópýl-metýl-[2-(3-n-própoxýfenoxý)-etýl]amíni | |
AR027876A4 (es) | Juntas para la fijacion de herrajes en cristales | |
PL344006A1 (en) | Α-(1-piperazinyl)acetamido arenecarboxylic acid derivatives as antidiabetic agents |